Evidence map›Paper›PMID 21360493›Full record

ArticleArthritis and rheumatism2011

Acquisition of the rheumatoid arthritis HLA shared epitope through microchimerism.

Zhen Yan, Tessa Aydelotte, V K Gadi, Katherine A Guthrie, J Lee Nelson

Open access · greenAbstract read
In one paragraph

Article in Arthritis and rheumatism, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
8.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 52 citations in OpenAlex.

  1. Identifying Key Questions and Challenges in Microchimerism Biology.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  2. Review
  3. Pregnancy and the Autoimmune Patient.Current allergy and asthma reports · 2024
    Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Immunogenicity of a rheumatoid arthritis protective sequence when acquired through microchimerism.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Adverse pregnancy outcomes and risk of subsequent rheumatoid arthritis.Arthritis & rheumatology (Hoboken, N.J.) · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Zhen YanFred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.
Tessa Aydelotte
V K Gadi
Katherine A Guthrie
J Lee Nelson
Fred Hutch Cancer Center · USCape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa · ZA

Funding

PREGNANCY, MICROCHIMERISM, AND AUTOIMMUNE DISEASER01AI041721 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI NELSON, J. LEE · 1997 to 2011
$4.2M
ALLOIMMUNITY IN AUTO IMMUNE DISEASER01AI045659 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI NELSON, J. LEE · 1999 to 2009
$3.4M
NIAID NIH HHS AI-41721NIAID NIH HHS AI-45659NIAID NIH HHS R01 AI041721NIAID NIH HHS R01 AI045659
6 · The paper itself

Abstract

objectiveHLA-DRB1 alleles associated with risk of rheumatoid arthritis (RA) encode similar HLA-DRB1 sequences, called the shared epitope (SE). The most common SE sequences are QKRAA and QRRAA. Nevertheless, a substantial number of RA patients lack the SE. Bidirectional fetal-maternal trafficking results in long-term persistence of fetal cells in the mother and maternal cells in her offspring, a process known as microchimerism. This study was undertaken to discover whether RA patients who lack the SE can acquire it through microchimerism.

methodsWe studied a total of 86 female subjects who were genotypically negative for the SE, comprising 52 patients with RA and 34 healthy controls. We developed specific real-time quantitative polymerase chain reaction assays for the SE-encoded sequences QKRAA and QRRAA, and used them to test DNA extracted from peripheral blood mononuclear cells.

resultsMicrochimerism with the SE was found significantly more often in RA patients than controls (odds ratio 4.1 [95% confidence interval 1.6-10.0], P = 0.003). Concentrations of SE microchimerism were also significantly higher among RA patients than controls (P = 0.002). In separate analyses for SE type, the prevalence of QKRAA microchimerism in RA patients versus healthy controls was 17% versus 3% (9 of 52 versus 1 of 34; P = 0.03) and the prevalence of QRRAA microchimerism was 40% versus 18% (21 of 52 versus 6 of 34; P = 0.04), respectively. Microchimerism concentrations were also higher in RA patients than healthy subjects for QKRAA (P = 0.03) and QRRAA (P = 0.03).

conclusionThese results indicate that RA patients who genotypically lack the SE can acquire the SE as persistent microchimerism from fetal-maternal cell exchange, suggesting that SE-encoding microchimerism could be a risk factor for RA.

Indexed as

ChimerismAdultAgedArthritis, RheumatoidEpitopesFemaleGenetic Predisposition to DiseaseHLA-DRB1 ChainsHumansLeukocytes, MononuclearMaleMaternal-Fetal ExchangeMiddle AgedPregnancyPrevalenceReal-Time Polymerase Chain ReactionEpitopesHLA-DRB1 Chains

Identifiers

PMID21360493
PMCPMC3188444
OpenAlexW2032800908

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.